Horizon Therapeutics Stock Plunges on Reports FTC Will Sue to Block Amgen Deal

Text size Amgen had aid it expected its acquisition of Horizon Therapeutics to be completed in the first half of 2023. Dreamstime Horizon Therapeutics stock plunged 18% early Tuesday on reports that the Federal Trade Commission is set to challenge Amgen ’s $27.8 billion deal to buy the biotech company. The FTC is expected to … Read more

Merck to Acquire Prometheus Biosciences

Merck to Acquire Prometheus Biosciences

BridgeBio Stock Surges on Dwarfism Drug Data. It’s Bad News for BioMarin.

Text size BridgeBio stock is soaring Monday. Dreamstime BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for an experimental treatment for achondroplasia, the most common type of short-limbed dwarfism. On Monday, BridgeBio (ticker: BBIO) said in a news release that its experimental drug Infigratinib showed … Read more

Amgen in Advanced Talks to Buy Horizon Therapeutics

Amgen Inc. AMGN -2.42% is in advanced talks to buy drug company Horizon Therapeutics HZNP 0.39% PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company was the last of three suitors … Read more